Global Cancer Stem Cell Therapy Market, Price, Dosage and Clinical Trial Insight 2025

  • No. of Pages: 225
  • Publish Date: July-2019
  • Category: Pharmaceutical and Healthcare
Electronic Access - Single User License
$3000
CD-ROM Mail Delivery
$4000
Hard Copy Mail Delivery
$4500
Electronic Access - Multi-User License
$5100

 

"Global Cancer Stem Cell Therapy Market, Price, Dosage and Clinical Trial Insight 2025" Report Highlights:

 

  • Role and Mechanism Of Stem Cells In Cancer Treatment

  • Stem Cell Transplantation In Cancer Treatment

  • Global Bone Marrow Transplant Market Opportunity : andgt; US$ 15 Billion

  • Global Cord Blood Transplant Market Opportunity

  • Cancer Stem Cell Therapy Clinical Pipeline: 37 Therapies

  • Majority Stem Cells In Preclinical Phase: 18 Therapies

  • Cancer Stem Cell Therapy Clinical Pipeline by Country: More Than 30 In USA

  • Post Therapy Cancer Stem Cell Targeting Drugs

 

Cancer incidences are escalating as a result of which demand for better therapeutics is increasing across the globe. There are several products in cancer market which have sufficiently high pharmacological efficiency and offers severe competition to other therapeutics belonging to same indication. Several cancer therapeutics have been developed in past years but they tend to become less effective in long-term. This creates large unmet medical needs as patients are not treated well despite the presence of suitable therapeutics. Cancer stem cell therapeutics are expected to change this scenario as they act on the very basis of development of cancer cells.

 

Innovations in pharmaceutical industry seem to be the main driving force for the development of cancer stem cell therapies. Investigators have been able to identify different stem cell sources which offers them large base for developing new therapies. Their customizability and appropriate usage is expected to help them to discover new pharmacological properties that may have high commercialization potential. As a result, large numbers of cancer stem cell therapies are entering in clinical trials across the globe.

 

Clinical pipeline of cancer stem cells therapies is quite strong due to which multiple number  of products are expected to be launched in global market in coming years. Development of stem cell therapies for CNS and CVS disorders has already gained lots of attention by investigators. Large population base and rapidly escalating cancer incidences are main factors behind growth of such investigational therapies. Budding stem cell therapies like development of cure for diabetes are also gaining momentum in past years. Less number of competitors is expected to increase the profit margins and allow cancer stem cell therapy developers to occupy major market shares. More stem cell therapies having high pharmacological and commercialization potential has yet to be discovered.

 

Several pharmaceutical companies are trying to develop different type of products that could target and eliminated cancer stem cells from the body. New candidates are at different stages of clinical trials which are expected to produce positive results. They are at different stages of clinical trials and they are expected to take some time before entering in market. Different methods are being studied targeting different mechanism by which cancer stem cells survive in the body. Different signaling pathways have been identified that play an important role in development of cancer stem cells.

 

The global stem cell therapy market is expected to witness favorable growth in future driven by the exponential increase in the research and development activities along with launch of 2 or more commercial stem cell therapies over a period of next 5 - 8 years. The shifting thrust towards targeted approach for cancer treatment will also create favorable environment for the development of stem cell therapies and will drive the overall market to new horizon in coming years.

Need custom market research solution? We can help you with that too.